Carillon Tower Advisers’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $3.36M | Sell |
72,136
-3,700
| -5% | -$172K | 0.02% | 439 |
|
|
2020
Q3 | $3.22M | Buy |
75,836
+25,540
| +51% | +$1.09M | 0.04% | 377 |
|
|
2020
Q2 | $2.41M | Sell |
50,296
-1,200
| -2% | -$57.6K | 0.02% | 425 |
|
|
2020
Q1 | $2.37M | Sell |
51,496
-5,500
| -10% | -$253K | 0.02% | 392 |
|
|
2019
Q4 | $3.42M | Sell |
56,996
-1,900
| -3% | -$114K | 0.02% | 423 |
|
|
2019
Q3 | $3.33M | Sell |
58,896
-500
| -0.8% | -$28.3K | 0.02% | 428 |
|
|
2019
Q2 | $3.31M | Buy |
59,396
+5,900
| +11% | +$328K | 0.02% | 428 |
|
|
2019
Q1 | $2.7M | Buy |
53,496
+300
| +0.6% | +$15.1K | 0.02% | 434 |
|
|
2018
Q4 | $2.14M | Buy |
53,196
+10,700
| +25% | +$431K | 0.02% | 428 |
|
|
2018
Q3 | $2.95M | Buy |
+42,496
| New | +$2.95M | 0.02% | 398 |
|